PLMJ advises Akanda Corp on €30m acquisition of Holigen
PLMJ has advised the Canadian company Akanda Corp, on its acquisition of Holigen Limited, the owner of the Portuguese company RPK Biopharma, from the Flowr Corporation. The transaction has been valued at approximately €30 million. The deal allows the Akanda Group to consolidate its leading position in the cultivation, production and marketing of herbal medicinal products in Europe, Africa and the Middle East.
RPK owns an indoor cannabis cultivation facility of approximately 7600 m2 in Sintra. It also owns an outdoor facility of nearly 40 hectares in the Alentejo municipality of Aljustrel, with a production capacity of around 100 tonnes of cannabis for medicinal purposes.
This multidisciplinary transaction was led by Eduardo Nogueira Pinto (pictured left), the partner who heads the Healthcare, Life Sciences and Pharmaceuticals practice, and Bárbara Godinho Correia (pictured right), a partner in the Corporate M&A practice.
This matter was also coordinated by Rita Albuquerque, a managing associate in the Corporate M&A practice, Ana Nunes Teixeira, an associate in the same practice area, and Ricardo Rocha, an associate in the Healthcare, Life Sciences and Pharmaceuticals practice.
The rest of the team was as follows: André Abrantes, Pedro Roque Coelho (associates in the Banking, Finance and Capital Markets practice), Filipa Vicente Silva (associate in the Real Estate and Tourism practice), Ana Nunes da Silva (associate in the Public Law practice), Margarida Ferraz de Oliveira (associate in Dispute Resolution practice), Roberto Carlos Rolo (associate in the Employment and Labour practice), and Inês Delgado Martins, Bartolomeu Soares de Oliveira, Rita Antunes da Cunha and Diogo Madeira Canário (trainee lawyers).
